Emyria Limited (ASX:EMD) signed an agreement to acquire The Pax Centre from Glenroyale Pty Ltd and Vivo (WA) Pty Ltd for AUD 1.7 million in June 2023. The acquisition is valued at $1.7m payable in a combination of shares (76%) and cash (24%) (the Acquisition) and signifies a landmark moment for Emyria's mission to expand and improve mental health care. A cash payment of $400,000, to be paid on a deferred basis on 1 October 2023; And; the issue of 10,236,220 fully paid ordinary shares in Emyria, (Consideration Shares). The acquisition remains subject to the completion of conditions precedent. Emyria completing legal and other relevant due diligence on the Company to its satisfaction. Each Seller executing a voluntary restriction agreement for their respective portion of the Consideration Shares. Each Seller entering into a services agreement and consulting agreement with Emyria to supersede and replace any prior agreements between each Seller and the Company. The parties having obtained all other approvals, consents, or waivers of a third party required to implement the Acquisition. Emyria will raise AUD 3.1 million and use AUD 0.5 million to fund the acquisition. The transaction is expected to complete in Q1 FY24.

Emyria Limited (ASX:EMD) completed the acquisition of The Pax Centre from Glenroyale Pty Ltd and Vivo (WA) Pty Ltd on September 13, 2023.